7
podcast episode
Ep. 108: No Silos, with Google Health’s David Feinberg and FasterCures’ Esther Krofah
“What we've really tried to do is get information out there to the public, to researchers, to publ
ic health folks, so they can make better decisions about what's happening so that we can all get through this.” - David Feinberg of Google Health
+ Read More
article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
+ Read More
report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering 
;the market and can identify multiple cancers early and simultaneously.
+ Read More
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
+ Read More
article
Comment Letter: Food and Drug Administration (FDA) – Medical Device User Fee Act (MDUFA)
Dear Commissioner Hahn:
article
Data Collection for Cell and Gene Therapies: Perspectives from the Front Lines
table td{padding:10px;}
In this Summary
Introduction
Framing the Challenge
Recommendations
Conclus
ion
+ Read More